Abnormality of vision
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Cerebral cortical atrophy
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Agitation, CTCAE 5.0
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Memory Impairment, CTCAE 5.0
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Alzheimer's Disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
(2) Four additional AD risk SNPs were nominally associated with obesity (rs17125944 at FERMT2, pBMI = 4.03 × 10(-05), pBMI corr = 2.50 × 10(-03) ; rs3851179 at PICALM; pBMI = 0.002, rs2075650 at TOMM40/APOE, pBMI = 0.024, rs3865444 at CD33, pBMI = 0.024).
|
24788522 |
2014 |
Obesity
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
(2) Four additional AD risk SNPs were nominally associated with obesity (rs17125944 at FERMT2, pBMI = 4.03 × 10(-05), pBMI corr = 2.50 × 10(-03) ; rs3851179 at PICALM; pBMI = 0.002, rs2075650 at TOMM40/APOE, pBMI = 0.024, rs3865444 at CD33, pBMI = 0.024).
|
24788522 |
2014 |
Charcot-Marie-Tooth disease, Type 2A
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Charcot-Marie-Tooth disease type 2A (CMT2A) is an autosomal dominant axonal form of peripheral neuropathy caused by mutations in the mitofusin 2 gene (MFN2), which encodes a mitochondrial outer membrane protein that promotes mitochondrial fusion.
|
21285398 |
2011 |
Alzheimer's Disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Alzheimer's disease susceptibility genes APOE and TOMM40, and hippocampal volumes in the Lothian birth cohort 1936.
|
24260406 |
2013 |
Alzheimer's Disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Alzheimer's disease susceptibility genes APOE and TOMM40, and brain white matter integrity in the Lothian Birth Cohort 1936.
|
24508314 |
2014 |
Alzheimer's Disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
TOMM40 risk alleles were approximately twice as frequent in AD subjects as controls.
|
19668339 |
2009 |
Psychotic Disorders
|
0.310 |
GeneticVariation
|
group |
BEFREE |
TOMM40 poly-T repeat lengths, age of onset and psychosis risk in Alzheimer disease.
|
21820212 |
2011 |
Nonorganic psychosis
|
0.310 |
GeneticVariation
|
disease |
BEFREE |
TOMM40 poly-T repeat lengths, age of onset and psychosis risk in Alzheimer disease.
|
21820212 |
2011 |
Alzheimer's Disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
TOMM40 poly-T repeat lengths, age of onset and psychosis risk in Alzheimer disease.
|
21820212 |
2011 |
Alzheimer's Disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
TOMM40 intron 6 poly-T length may explain some of the variation in age at onset in PSEN2 familial AD and may be associated with AD neuropathology in persons with APOE ε3/ε3.
|
23183136 |
2013 |
Parkinson Disease
|
0.050 |
GeneticVariation
|
disease |
BEFREE |
TOMM40 and APOE common genetic variants are not Parkinson's disease risk factors.
|
23522842 |
2013 |
Alzheimer's Disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
TOMM40 polymorphisms in Italian Alzheimer's disease and frontotemporal dementia patients.
|
23546992 |
2013 |
Pick Disease of the Brain
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
TOMM40 polymorphisms in Italian Alzheimer's disease and frontotemporal dementia patients.
|
23546992 |
2013 |
Frontotemporal dementia
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
TOMM40 polymorphisms in Italian Alzheimer's disease and frontotemporal dementia patients.
|
23546992 |
2013 |
Parkinson Disease
|
0.050 |
Biomarker
|
disease |
BEFREE |
TOM40 mediates mitochondrial dysfunction induced by α-synuclein accumulation in Parkinson's disease.
|
23626796 |
2013 |
Unipolar Depression
|
0.310 |
GeneticVariation
|
disease |
BEFREE |
TOMM40 rs2075650 may represent a new candidate gene for vulnerability to major depressive disorder.
|
24549102 |
2014 |
Major Depressive Disorder
|
0.310 |
GeneticVariation
|
disease |
BEFREE |
TOMM40 rs2075650 may represent a new candidate gene for vulnerability to major depressive disorder.
|
24549102 |
2014 |
Unipolar Depression
|
0.310 |
Biomarker
|
disease |
PSYGENET |
TOMM40 rs2075650 may represent a new candidate gene for vulnerability to major depressive disorder.
|
24549102 |
2014 |
Major Depressive Disorder
|
0.310 |
Biomarker
|
disease |
PSYGENET |
TOMM40 rs2075650 may represent a new candidate gene for vulnerability to major depressive disorder.
|
24549102 |
2014 |
Alzheimer's Disease
|
0.500 |
AlteredExpression
|
disease |
BEFREE |
TOMM40 gene expression remained significantly lower in AD patients at all time-points compared to controls, supported by confirmatory RT-PCR results.
|
25201778 |
2015 |
Mental deterioration
|
0.130 |
Biomarker
|
phenotype |
BEFREE |
TOMM40 and APOE Gene Expression and Cognitive Decline in Japanese Alzheimer's Disease Subjects.
|
28984592 |
2017 |